Indication
Hereditary factor X deficiency disease
Hereditary factor X deficiency disease is an ultra-rare, autosomal recessive bleeding disorder of the hematologic system caused by pathogenic variants in the *F10* gene. Read more about Hereditary factor X deficiency disease
1 drugs 1 manufacturers
Drugs that treat it
Common Hereditary factor X deficiency disease therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHereditary factor X deficiency disease is an ultra-rare, autosomal recessive bleeding disorder of the hematologic system caused by pathogenic variants in the *F10* gene.
Because factor X serves as the critical serine protease initiating the common pathway of the coagulation cascade, its quantitative or qualitative deficiency severely impairs thrombin generation and clot formation.
Affecting males and females equally, clinical severity varies widely, ranging from mild mucocutaneous bleeding—such as recurrent epistaxis, menorrhagia, and hematuria—to severe, life-threatening manifestations.
In severe cases, symptoms typically present early in life with umbilical stump bleeding, recurrent hemarthroses, deep muscle hematomas, or catastrophic intracranial and gastrointestinal hemorrhages.
- nih.gov
Hereditary factor X deficiency disease is an ultra-rare, autosomal recessive bleeding disorder of the hematologic system caused by pathogenic variants in the *F10* gene Because factor X serves as the critical serine protease initiating the common pathway of the coagulation cascade, its quantitative or qualitative deficiency severely impairs thrombin generation and clot formation Affecting males and females equally, clinical severity varies widely, ranging from mild mucocutaneous bleeding—such as...
- medicover-genetics.com
Hereditary factor X deficiency disease is an ultra-rare, autosomal recessive bleeding disorder of the hematologic system caused by pathogenic variants in the *F10* gene Because factor X serves as the critical serine protease initiating the common pathway of the coagulation cascade, its quantitative or qualitative deficiency severely impairs thrombin generation and clot formation
- nih.gov
Affecting males and females equally, clinical severity varies widely, ranging from mild mucocutaneous bleeding—such as recurrent epistaxis, menorrhagia, and hematuria—to severe, life-threatening manifestations
- bleeding.org
Affecting males and females equally, clinical severity varies widely, ranging from mild mucocutaneous bleeding—such as recurrent epistaxis, menorrhagia, and hematuria—to severe, life-threatening manifestations In severe cases, symptoms typically present early in life with umbilical stump bleeding, recurrent hemarthroses, deep muscle hematomas, or catastrophic intracranial and gastrointestinal hemorrhages
- thebloodproject.com
In severe cases, symptoms typically present early in life with umbilical stump bleeding, recurrent hemarthroses, deep muscle hematomas, or catastrophic intracranial and gastrointestinal hemorrhages
Personalize your experience
Follow Hereditary factor X deficiency disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.